Intimation of publication of unaudited standalone financial results of the company for the quarter and half year ended september 30,2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed BSE that its unaudited standalone financial results for the quarter and half year ended September 30, 2025 have been published in newspapers as required by SEBI listing rules. The results were published in Financial Express (English) and Jansatta (Hindi), both New Delhi editions. This is a routine compliance filing under Regulation 30 of SEBI's LODR Regulations, 2015. The company secretary, Pallavi Garg, signed the intimation dated November 15, 2025. No specific financial numbers for Kimia Biosciences were visible in the filing content provided.
This is a procedural regulatory disclosure with no direct material impact on shareholders. Investors should look at the actual published financial results (available on BSE's website) to assess the company's Q2 FY26 performance.